ClinicalTrials.Veeva

Menu

Giessen Pulmonary Hypertension Registry and Biobank

U

University of Giessen

Status

Enrolling

Conditions

Pulmonary Hypertension

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Giessen Pulmonary Hypertension Registry and Biobank

Full description

Long-term transplant-free survival and its determinants will be investigated in patients with Pulmonary Hypertension (diagnosed by right heart catheterization) within a prospective registry at a single referral center in Giessen, Germany.

Enrollment

10,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Right heart catheterization for PH diagnosis in Giessen

Exclusion criteria

  • informed consent missing

Trial design

10,000 participants in 6 patient groups

Pulmonary arterial hypertension
Description:
Group 1 PH
Pulmonary hypertension due to left heart disease
Description:
Group 2 PH
Pulmonary hypertension due to lung disease
Description:
Group 3 PH
Chronic thromboembolic pulmonary hypertension
Description:
Group 4 PH
Miscellaneous
Description:
Group 5 PH
Exclusion PH
Description:
Patient with invasively excluded PH

Trial contacts and locations

1

Loading...

Central trial contact

Khodr Tello, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems